Ioannis T. Farmakis

5 ta ish

AHEPA University Hospital

1. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design

   Aristi Boulmpou, Αναστάσιος Κάρτας, Ioannis T. Farmakis +9

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.661373

2. Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome

   Ioannis T. Farmakis, Stefanos Zafeiropoulos, Areti Pagiantza +9

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.661376

3. Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome

   Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +15

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.661377

4. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

   Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +6

   PreprintOAOchiq kirishLipoproteins and Cardiovascular HealthResearch Square20200 iqtibos

   ABIABI:AkademIndex/2020.preprint.000048

5. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

   Stefanos Zafeiropoulos, Ioannis T. Farmakis, George Giannakoulas +1

   PreprintOAOchiq kirishLipoproteins and Cardiovascular HealthResearch Square20200 iqtibos

   ABIABI:AkademIndex/2020.preprint.000099